Clear Street’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Clear Street's EBACW Position: Q1 2023 in Review

Clear Street sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 217,000 shares — an estimated $65K sold.

Clear Street first reported a position in EBACW in Q3 2022 and held it in 2 quarters. The position peaked at $65K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

• Clear Street reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
• Clear Street sold 217,000 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $65K.
• Clear Street first reported a position in European Biotech Acquisition Corp. Warrant in Q3 2022 and held it in 2 quarters.
• Clear Street's European Biotech Acquisition Corp. Warrant position peaked at $65K in Q4 2022.
• 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Clear Street's 13F filing for Q1 2023, filed 12 May 2023.